Moreover, several reports have shown that abnormal expression of UBE2I results in occurrence and progression of multiple human cancers, including breast cancer [11, 12], glioma [13, 14], lung cancer [15], head and neck squamous cell carcinoma [16], osteosarcoma [17] and hepatocellular carcinoma [18]. Here, UBE2I is linked to cancer.